US - HealthQuill

American beekeepers lost nearly half of their managed colonies even as honeybee hives buzzed through their second-highest death rate on record to remain “relatively stable,” according to Bee Informed Partnership.

US beekeepers lose half of managed colonies, hives death rate rise

HQ Team June 28: 2023: American beekeepers lost nearly half of their managed colonies even as honeybee hives buzzed through their second-highest death.

by HealthQuill
June 28, 2023
0 Comments

For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states, Florida and Texas, according to the Centres for Disease Control and Prevention.

Drugs Health Pharma

US issues advisory as locally acquired malaria resurfaces after 20 years

HQ Team June 27, 2023: For the first time in 20 years, locally-acquired cases of malaria have been detected in two US states,.

by HealthQuill
June 27, 2023
0 Comments

The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.

Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

by HealthQuill
June 20, 2023
0 Comments

Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s ‘no action required’ classification for its domestic facility in the country’s south.

Drugs Health Pharma Uncategorized

India’s Lupin unveils thiamine injection in US, receives FDA’s NAR for Vizag unit

HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s.

by HealthQuill
June 20, 2023
0 Comments

Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.

Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

by HealthQuill
June 13, 2023
0 Comments

Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental trials of two drugs to treat chronic kidney diseases.

Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.

by HealthQuill
June 13, 2023
0 Comments

AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to develop cell therapies for treating autoimmune diseases.

Drugs Health Pharma

AstraZeneca signs $2 billion deal for autoimmune diseases

HQ Team June 9, 2023: AstraZeneca, a British-Swedish pharmaceutical company, has signed a deal, worth more than $2 billion, with Quell Therapeutics to.

by HealthQuill
June 9, 2023
0 Comments

AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the disease, according to a company statement.

Drugs Health Medical Pharma

AstraZeneca’s drug cuts risk of lung cancer death by 51%, trials show

HQ Team June 5, 2023: AstraZeneca’s lung cancer drug, Tagrisso, reduced the risk of death by 51% in the early stages of the.

by HealthQuill
June 5, 2023
0 Comments

Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced.

Drugs Health Medical Pharma

Pfizer: ’Positive results’ emerge out of multi-drug-resistant trials

HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.